The cell-mediated immune response induced by plasmid encoding bovine herpesvirus 1 glycoprotein B is enhanced by plasmid encoding IL-12 when delivered intramuscularly or by gene gun, but not after intradermal injection

Vaccine

Volumn 24, Issue 25, 2006, Pages 5349-5359

  Huang, Y ^a   Babiuk, L A ^a   van Drunen Littel van den Hurk, S ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Cytotoxic T cell response; DNA vaccine; Glycoprotein B; IL 12

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN B; IMMUNOGLOBULIN G2A; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BOVINE HERPES VIRUS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; GENE GUN; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; INJECTION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; STIMULATION;

ANIMALS; ANTIBODIES, VIRAL; BIOLISTICS; CATTLE; CERCOPITHECUS AETHIOPS; COS CELLS; HERPESVIRUS 1, BOVINE; HERPESVIRUS VACCINES; HUMANS; IMMUNIZATION; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-12; MICE; MICE, INBRED C3H; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 33744516498     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.026     Document Type: Article

References (59)

1. Eskra L., and Splitter G.A. Bovine herpesvirus-1 infects activated CD4+ lymphocytes. J Gen Virol 78 Pt 9 (1997) 2159-2166
2. Nataraj C., Eidmann S., Hariharan M.J., Sur J.H., Perry G.A., and Srikumaran S. Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules. Viral Immunol 10 1 (1997) 21-34
3. Hariharan M.J., Nataraj C., and Srikumaran S. Down regulation of murine MHC class I expression by bovine herpesvirus 1. Viral Immunol 6 4 (1993) 273-284
4. Tighe H., Corr M., Roman M., and Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 19 2 (1998) 89-97
5. Byrne K.M., Horohov D.W., and Kousoulas K.G. Glycoprotein B of bovine herpesvirus-1 binds heparin. Virology 209 1 (1995) 230-235
6. Li Y., van Drunen Littel-van den Hurk S., Liang X., and Babiuk L.A. Functional analysis of the transmembrane anchor region of bovine herpesvirus 1 glycoprotein gB. Virology 228 1 (1997) 39-54
7. Kuhn J.E., Klaffke K., Munk K., and Braun R.W. HSV-1 gB and VZV gp-II crossreactive antibodies in human sera. Arch Virol 112 3-4 (1990) 203-213
8. Fuller A.O., and Lee W.C. Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. J Virol 66 8 (1992) 5002-5012
9. Miethke A., Keil G.M., Weiland F., and Mettenleiter T.C. Unidirectional complementation between glycoprotein B homologues of pseudorabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule. J Gen Virol 76 Pt 7 (1995) 1623-1635
10. Misra V., Blumenthal R.M., and Babiuk L.A. Proteins Specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J Virol 40 2 (1981) 367-378
11. van Drunen Littel-van den Hurk S., Gifford G.A., and Babiuk L.A. Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 8 4 (1990) 358-368
12. Fitzpatrick D.R., Redmond M.J., Attah-Poku S.K., van Drunen Littel-van den Hurk S., Babiuk L.A., and Zamb T.J. Mapping of 10 epitopes on bovine herpesvirus type 1 glycoproteins gI and gIII. Virology 176 1 (1990) 145-157
13. Huang Y., Babiuk L.A., and van Drunen Littel-van den Hurk S. Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J Gen Virol 86 Pt 4 (2005) 887-898
14. Loehr B.I., Pontarollo R., Rankin R., Latimer L., Willson P., Babiuk L.A., et al. Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine. J Gen Virol 82 Pt 12 (2001) 3035-3043
15. Chan S.H., Perussia B., Gupta J.W., Kobayashi M., Pospisil M., Young H.A., et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173 4 (1991) 869-879
16. Gubler U., Chua A.O., Schoenhaut D.S., Dwyer C.M., McComas W., Motyka R., et al. Co-expression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 88 10 (1991) 4143-4147
17. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170 3 (1989) 827-845
18. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 2 (2003) 133-146
19. Graham B.S., Henderson G.S., Tang Y.W., Lu X., Neuzil K.M., and Colley D.G. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 151 4 (1993) 2032-2040
20. Metzger D.W., McNutt R.M., Collins J.T., Buchanan J.M., Van Cleave V.H., and Dunnick W.A. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur J Immunol 27 8 (1997) 1958-1965
21. Gherardi M.M., Ramirez J.C., and Esteban M. Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime-booster vaccination regimens. Histol Histopathol 16 2 (2001) 655-667
22. Szabo S.J., Sullivan B.M., Peng S.L., and Glimcher L.H. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 21 (2003) 713-758
23. Barth H., Klein R., Berg P.A., Wiedenmann B., Hopf U., and Berg T. Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B. Hepatogastroenterology 48 38 (2001) 553-555
24. Park A.Y., Hondowicz B., Kopf M., and Scott P. The role of IL-12 in maintaining resistance to Leishmania major. J Immunol 168 11 (2002) 5771-5777
25. Afonso L.C., Scharton T.M., Vieira L.Q., Wysocka M., Trinchieri G., and Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263 5144 (1994) 235-237
26. Arulanandam B.P., O'Toole M., and Metzger D.W. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J Infect Dis 180 4 (1999) 940-949
27. Babiuk L.A., Pontarollo R., Babiuk S., Loehr B., and van Drunen Littel-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 21 7-8 (2003) 649-658
28. Podlaski F.J., Nanduri V.B., Hulmes J.D., Pan Y.C., Levin W., Danho W., et al. Molecular characterization of interleukin 12. Arch Biochem Biophys 294 1 (1992) 230-237
29. Krieg A.M., Wu T., Weeratna R., Efler S.M., Love-Homan L., Yang L., et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA 95 21 (1998) 12631-12636
30. Pontarollo R.A., Babiuk L.A., Hecker R., and Van Drunen Littel-Van Den Hurk S. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J Gen Virol 83 Pt 12 (2002) 2973-2981
31. Baca-Estrada M.E., Snider M., Tikoo S.K., Harland R., Babiuk L.A., and van Drunen Littel-van den Hurk S. Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses. Viral Immunol 9 1 (1996) 11-22
32. Bermudez-Humaran L.G., Langella P., Cortes-Perez N.G., Gruss A., Tamez-Guerra R.S., Oliveira S.C., et al. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun 71 4 (2003) 1887-1896
33. Maecker H.T., Umetsu D.T., DeKruyff R.H., and Levy S. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin. Vaccine 15 15 (1997) 1687-1696
34. Chen B., Timiryasova T.M., Gridley D.S., Andres M.L., Dutta-Roy R., and Fodor I. Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy. Cytokine 15 6 (2001) 305-314
35. Lui V.W., Falo Jr. L.D., and Huang L. Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo. J Gene Med 3 4 (2001) 384-393
36. Ling P., Gately M.K., Gubler U., Stern A.S., Lin P., Hollfelder K., et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154 1 (1995) 116-127
37. Lee Y.L., Ye Y.L., Yu C.I., Wu Y.L., Lai Y.L., Ku P.H., et al. Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma. Hum Gene Ther 12 17 (2001) 2065-2079
38. Gillessen S., Carvajal D., Ling P., Podlaski F.J., Stremlo D.L., Familletti P.C., et al. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 25 1 (1995) 200-206
39. Wu S.F., Liao C.L., Lin Y.L., Yeh C.T., Chen L.K., Huang Y.F., et al. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Vaccine 21 25-26 (2003) 3919-3929
40. Lee S., Gierynska M., Eo S.K., Kuklin N., and Rouse B.T. Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Microbes Infect 5 7 (2003) 571-578
41. Matsui M., Moriya O., and Akatsuka T. Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid. Vaccine 21 15 (2003) 1629-1639
42. Sykes K.F., Lewis M.G., Squires B., and Johnston S.A. Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge. Vaccine 20 17-18 (2002) 2382-2395
43. Schirmbeck R., and Reimann J. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12. Intervirology 44 2-3 (2001) 115-123
44. Hanlon L., Argyle D., Bain D., Nicolson L., Dunham S., Golder M.C., et al. Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. J Virol 75 18 (2001) 8424-8433
45. Yoshida S., Tanaka T., Kita Y., Kuwayama S., Kanamaru N., Muraki Y., et al. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation. Vaccine 24 8 (2006) 1191-1204
46. Chattergoon M.A., Saulino V., Shames J.P., Stein J., Montaner L.J., and Weiner D.B. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine 22 13-14 (2004) 1744-1750
47. Yamakami K., Akao S., Sato M., Nitta Y., Miyazaki J., and Tadakuma T. A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection. Parasitol Int 50 2 (2001) 81-91
48. Schadeck E.B., Sidhu M., Egan M.A., Chong S.Y., Piacente P., Masood A., et al. A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine (2005)
49. Chen H.W., Pan C.H., Huan H.W., Liau M.Y., Chiang J.R., and Tao M.H. Suppression of immune response and protective immunity to a Japanese encephalitis virus DNA vaccine by coadministration of an IL-12-expressing plasmid. J Immunol 166 12 (2001) 7419-7426
50. Williman J., Lockhart E., Slobbe L., Buchan G., and Baird M. The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun. Vaccine (2005)
51. Wu S., Pascual D.W., Lewis G.K., and Hone D.M. Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector. AIDS Res Hum Retroviruses 13 14 (1997) 1187-1194
52. Yoshida A., Nagata T., Uchijima M., Higashi T., and Koide Y. Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine 18 17 (2000) 1725-1729
53. Boyle J.S., Koniaras C., and Lew A.M. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol 9 12 (1997) 1897-1906
54. van Drunen Littel-van den Hurk S., Braun R.P., Karvonen B.C., King T., Yoo D., and Babiuk L.A. Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins. Virology 260 1 (1999) 35-46
55. Lewis P.J., van Drunen Littel-van den H., and Babiuk L.A. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J Virol 73 12 (1999) 10214-10223
56. Feltquate D.M., Heaney S., Webster R.G., and Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158 5 (1997) 2278-2284
57. Caselli E., Boni M., Di Luca D., Salvatori D., Vita A., and Cassai E. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice. Comp Immunol Microbiol Infect Dis 28 2 (2005) 155-166
58. Gogev S., Vanderheijden N., Lemaire M., Schynts F., D'Offay J., Deprez I., et al. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine 20 9-10 (2002) 1451-1465
59. Hussell T., and Humphreys I.R. Nasal vaccination induces protective immunity without immunopathology. Clin Exp Immunol 130 3 (2002) 359-362